NCT02247505

CKD-397 Drug-drug Interaction Study (B)

A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Pharmacokinetic Effect of Tadalafil on Tamsulosin in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 29 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate to effect of tadalafil on the pharmacokinetic properies of tamsulosin

Detailed description

This study is a randomized, open-label, mutiple dosing, 2-way crossover design to evaluate the pharmacokinetic effect of tadalafil(5mg) on tamsulosin(0.2mg) in healthy male subjects Subjects will receive repeated dose of tamsulosin (0.2mg\*1t/day) or tamsulosin (0.2mg\*1t/day) / tadalafil (5mg\*1t/day) for 5days Each treatment period was separated by a washout period of at least 10 days. Each period of study will enroll 14 healthy male subjects. Blood samples for pharmacokinetic analysis will be taken at regular intervals after dosing. Safety will be assessed by measurement of blood pressure, heart rate, safety laboratory data, and review of adverse events.

Conditions

• Healty Male Volunteers

Interventions

Type	Name	Description
DRUG	Harnal-D Cap. 0.2mg
DRUG	Cialis Tab. 5mg

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-10-01
• Completion: 2014-12-01
• First posted: 2014-09-25
• Last updated: 2015-08-20

Locations

1 site across 1 country: South Korea